Login using IAM
The administered radionuclide activities and measured dose rates that shall be considered to decide the immediate release of patients from the licensee control are listed in the following table.
The dose constraints per episode for different categories which should be considered before the release of patients are listed in the following table.
The following table includes residual radionuclide activities and time periods for which instructions shall be followed by patients *.
* For Cu-64, I-123, Re-188 and Tc-99m the period for which instructions must be followed is 24 h.
The following table lists the activities of radiopharmaceuticals above which instructions shall be provided to patients who could breastfeed an infant or child regarding the interruption or cessation of breastfeeding.
Last update: 28 April 2025
You can browse the portal by giving voice commands using the microphone
Speak Now...
Please give voice commands from the following options:
Disclaimer: Translation into other languages depends on the Google translation, Therefor the NCC is not responsible for the accuracy of the information in the new language.